Daniel Jacoby
Daniel Jacoby
Verified email at
Cited by
Cited by
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ...
The Lancet 396 (10253), 759-769, 2020
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, ...
Circulation 138 (14), 1387-1398, 2018
Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)
MS Maurer, M Hanna, M Grogan, A Dispenzieri, R Witteles, B Drachman, ...
Journal of the American College of Cardiology 68 (2), 161-172, 2016
Empagliflozin in heart failure: diuretic and cardiorenal effects
M Griffin, VS Rao, J Ivey-Miranda, J Fleming, D Mahoney, C Maulion, ...
Circulation 142 (11), 1028-1039, 2020
Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy
ED Smith, NK Lakdawala, N Papoutsidakis, G Aubert, A Mazzanti, ...
Circulation 141 (23), 1872-1884, 2020
Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial
SB Heitner, D Jacoby, SJ Lester, A Owens, A Wang, D Zhang, J Lambing, ...
Annals of internal medicine 170 (11), 741-748, 2019
Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy
CY Ho, ME Mealiffe, RG Bach, M Bhattacharya, L Choudhury, ...
Journal of the American College of Cardiology 75 (21), 2649-2660, 2020
Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
CN Toepfer, AC Garfinkel, G Venturini, H Wakimoto, G Repetti, L Alamo, ...
Circulation 141 (10), 828-842, 2020
Genetics of inherited cardiomyopathy
D Jacoby, WJ McKenna
European heart journal 33 (3), 296-304, 2012
Transthyretin stabilization by AG10 in symptomatic transthyretin amyloid cardiomyopathy
DP Judge, SB Heitner, RH Falk, MS Maurer, SJ Shah, RM Witteles, ...
Journal of the American College of Cardiology 74 (3), 285-295, 2019
Machine learning prediction of mortality and hospitalization in heart failure with preserved ejection fraction
S Angraal, BJ Mortazavi, A Gupta, R Khera, T Ahmad, NR Desai, ...
JACC: Heart Failure 8 (1), 12-21, 2020
Update on hypertrophic cardiomyopathy and a guide to the guidelines
S Sen-Chowdhry, D Jacoby, JC Moon, WJ McKenna
Nature Reviews Cardiology 13 (11), 651-675, 2016
Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure
JM Testani, JS Hanberg, S Cheng, V Rao, C Onyebeke, O Laur, A Kula, ...
Circulation: Heart Failure 9 (1), e002370, 2016
Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe registry
P Marstrand, L Han, SM Day, I Olivotto, EA Ashley, M Michels, AC Pereira, ...
Circulation 141 (17), 1371-1383, 2020
Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM cardiac magnetic resonance substudy analysis
S Saberi, N Cardim, M Yamani, J Schulz-Menger, W Li, V Florea, ...
Circulation 143 (6), 606-608, 2021
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase …
JA Spertus, JT Fine, P Elliott, CY Ho, I Olivotto, S Saberi, W Li, C Dolan, ...
The Lancet 397 (10293), 2467-2475, 2021
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy
R Walsh, F Mazzarotto, N Whiffin, R Buchan, W Midwinter, A Wilk, N Li, ...
Genome medicine 11 (1), 1-18, 2019
Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure
JM Testani, JS Hanberg, JP Arroyo, MA Brisco, JM Ter Maaten, FP Wilson, ...
European journal of heart failure 18 (6), 660-668, 2016
Substantial discrepancy between fluid and weight loss during acute decompensated heart failure treatment
JM Testani, MA Brisco, RD Kociol, D Jacoby, L Bellumkonda, CR Parikh, ...
The American journal of medicine 128 (7), 776-783. e4, 2015
Compensatory distal reabsorption drives diuretic resistance in human heart failure
VS Rao, N Planavsky, JS Hanberg, T Ahmad, MA Brisco-Bacik, FP Wilson, ...
Journal of the American Society of Nephrology: JASN 28 (11), 3414, 2017
The system can't perform the operation now. Try again later.
Articles 1–20